IREN, Convertible and senior notes
Digest more
In the realm of biotech and pharmaceuticals, fundraising often plays a pivotal role in driving innovation and progress. Biotech and pharmaceutical companies, whether private startups or established ...
Convertible instruments held steady in Q1 2025, but the terms are shifting in favor of investors. Interest rates on convertible notes rose by 200 to 300 basis points, and discount rates climbed as ...
Major fundraising move: Tyler Technologies will sell $1B in convertible senior notes due 2031, with an option for an extra $150M. Use of proceeds: Funds will go toward capped call transactions, ...
Repurchased $225 million principal amount of convertible notes removing approximately 8.3 million underlying shares as well as approximately $63.8 million of remaining interest Issued 9.45 million ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results